drugset / Trial / NCT00679601
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
Open-labelTreatment
Summary
The purpose of the study is to determine the absorption and systemic pharmacokinetics of AN2690 following daily application to all ten (10) toenails for 28 days.
Timeline
- Start
- 2007-03-31
- Primary completion
- 2007-05-31
- Completion
- 2007-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tavaborole | Small molecule | 7.5 % | Topical |